The homeobox protein VENTX is antagonist of the Wnt signalling pathway and has shown to be dysregulated in the immune cells of the tumour microenvironment (TME), being a potential target for immunotherapy (Reviewed in68). This evidence concerns the gene POU2F2 and neoplasm.